Skip to search formSkip to main contentSkip to account menu

fusafungin

Known as: C29H51N2O8, Fusafungine 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

AerosolsAnti-Bacterial AgentsFusarium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study
Knowledge on unintended consequences of product withdrawals is limited. Fusafungine, indicated for treatment of upper respiratory… 
Review
2015
Review
2015
Antibiotics for acute laryngitis in adults.
BACKGROUND This is an update of the original review published in 2005. Acute laryngitis is a common illness worldwide. Diagnosis… 
2002
2002
Efficacy and Acceptability of Fusafungine*, a Local Treatment for Both Nose and Throat Infections, in Adult Patients with Upper Respiratory Tract Infections
Summary The objective of this study was to assess the effectiveness and acceptability of fusafungine in the treatment of patients… 
2002
2002
Topical Treatment of Rhinosinusitis with Fusafungine Nasal Spray
Summary In a monocenter, placebo-controlled, double-blind, parallel-group study, 20 patients with acute symptoms of rhino… 
2001
2001
Fusafungine, an Antimicrobial with Anti-Inflammatory Properties in Respiratory Tract Infections
Following bacterial or viral infection, an inflammatory reaction develops that is aimed at the capture and destruction of the… 
1998
1998
Expression and modulation of ICAM-1, TNF-alpha and RANTES in human alveolar macrophages from lung-transplant recipients in vitro.
1997
1997
FUSAFUNGINE REDUCES SYMPTOMS OF UPPER RESPIRATORY TRACT INFECTIONS (URTI) IN RUNNERS AFTER A 56KM RACE 1685
1996
1996
Modulation of ICAM-1 expression in human alveolar macrophages in vitro.
Modulation of intercellular adhesion molecule-1 (ICAM-1) expression may be a basic mechanism by which alveolar macrophages (AMs… 
1996
1996
FUSAFUNGINE : AN ANTIMICROBIAL AGENT FOR THE LOCAL TREATMENT OF RESPIRATORY TRACT INFECTIONS
1990
1990
[In vitro evaluation of antimicrobial activity of fusafungine].
Fusafungine is an antibiotic extracted from the fungus Fusarium laterium WR strain 437. The antimicrobial activity of fusafungine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)